CN117159482A — 一种左乙拉西坦口崩片及其制备方法
Assigned to Wanquan Wante Pharmaceutical Jiangsu Co ltd · Expires 2023-12-05 · 2y expired
What this patent protects
本发明属于药物制剂领域，具体涉及一种左乙拉西坦口崩片及其制备方法。所述左乙拉西坦口崩片包含左乙拉西坦50%、填充剂20%~35%、崩解剂10%~20%、矫味剂0.1%~0.5%、润滑剂1%~5%。本发明通过优选填充剂、崩解剂等辅料的比例及加入方式，同时加入矫味剂，提高药物口感，优化制备工艺，缩短了崩解时限，增加了口崩片的韧性，使得药片不易脆碎，方便运输，提高了患者顺应性。
USPTO Abstract
本发明属于药物制剂领域，具体涉及一种左乙拉西坦口崩片及其制备方法。所述左乙拉西坦口崩片包含左乙拉西坦50%、填充剂20%~35%、崩解剂10%~20%、矫味剂0.1%~0.5%、润滑剂1%~5%。本发明通过优选填充剂、崩解剂等辅料的比例及加入方式，同时加入矫味剂，提高药物口感，优化制备工艺，缩短了崩解时限，增加了口崩片的韧性，使得药片不易脆碎，方便运输，提高了患者顺应性。
Drugs covered by this patent
- Keppra (levetiracetam) · Generic (originally UCB Pharma)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.